BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28846693)

  • 21. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
    Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
    Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
    Zhou Y; Tong L; Chu X; Deng F; Tang J; Tang Y; Dai Y
    Cell Physiol Biochem; 2017; 43(2):733-742. PubMed ID: 28950257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
    Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
    Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
    Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
    PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.
    Huang L; Peng Y; Zhong G; Xie W; Dong W; Wang B; Chen X; Gu P; He W; Wu S; Lin T; Huang J
    Oncotarget; 2015 Jun; 6(18):16366-78. PubMed ID: 25978027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
    Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
    Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis.
    Lee CH; Hung PF; Lu SC; Chung HL; Chiang SL; Wu CT; Chou WC; Sun CY
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation.
    Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY
    Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.
    Arakaki R; Yamasaki T; Kanno T; Shibasaki N; Sakamoto H; Utsunomiya N; Sumiyoshi T; Shibuya S; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
    Cancer Med; 2016 Oct; 5(10):2920-2933. PubMed ID: 27666332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
    Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
    Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G Protein Alpha S Subunit Promotes Cell Proliferation of Renal Cell Carcinoma with Involvement of Protein Kinase A Signaling.
    Zhang B; Sun N; Mu X; Zhi L; Zhai L; Jiang Y; Fu Z; Yao Z
    DNA Cell Biol; 2017 Mar; 36(3):237-242. PubMed ID: 28051330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
    Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
    Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
    [No Abstract]   [Full Text] [Related]  

  • 37. Apigenin inhibits renal cell carcinoma cell proliferation.
    Meng S; Zhu Y; Li JF; Wang X; Liang Z; Li SQ; Xu X; Chen H; Liu B; Zheng XY; Xie LP
    Oncotarget; 2017 Mar; 8(12):19834-19842. PubMed ID: 28423637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
    Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
    Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of HMGB2 inhibits proliferation and invasion of renal tumor cells via the p-38MAPK pathway.
    He ZH; Guo F; Hu XX; Luo ZY; Yi JW
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4729-4737. PubMed ID: 32432736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.